41 – 50 of 90
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Genomic characterization of non-small cell lung cancer - clinical and molecular implications
(
- Thesis › Doctoral thesis (compilation)
-
Mark
An Integrative Analysis of Transcriptome and Epigenome Features of ASCL1–Positive Lung Adenocarcinomas
(
- Contribution to journal › Article
-
Mark
Smoking is the most significant modifiable lung cancer risk factor in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Epithelial–mesenchymal transition, a spectrum of states : Role in lung development, homeostasis, and disease
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis
(
- Contribution to journal › Article
-
Mark
Liquid fiducial marker applicability in proton therapy of locally advanced lung cancer
(
- Contribution to journal › Article
- 2016
-
Mark
Prevalence of Sudden Death in Palliative Care : Data From the Australian Palliative Care Outcomes Collaboration
(
- Contribution to journal › Article
-
Mark
Anthropometry and the risk of lung cancer in EPIC
(
- Contribution to journal › Article
- 2015
-
Mark
The added value of hybrid ventilation/perfusion SPECT/CT in patients with stable COPD or apparently healthy smokers. Cancer-suspected CT findings in the lungs are common when hybrid imaging is used
(
- Contribution to journal › Article
- 2014
-
Mark
Tumor-propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasis
(
- Contribution to journal › Article